Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes
about
Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteinsRelease of GPI-anchored membrane proteins by a cell-associated GPI-specific phospholipase DParoxysmal nocturnal hemoglobinuria from bench to bedsideComparative functional evolution of human and mouse CR1 and CR2Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complementHow I treat paroxysmal nocturnal hemoglobinuriaCD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cellsDelivery of drugs bound to erythrocytes: new avenues for an old intravascular carrierComplement regulation of T-cell alloimmunityComplement regulation of T cell immunityEffects of complement activation on allograft injuryBiomedical applications of glycosylphosphatidylinositol-anchored proteinsMapping CD55 function. The structure of two pathogen-binding domains at 1.7 ASolution structure of a functionally active fragment of decay-accelerating factorStructure/function studies of human decay-accelerating factorPIG-A mutations in paroxysmal nocturnal hemoglobinuria and in normal hematopoiesisRole of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targetingFunctional properties of membrane cofactor protein of complementC3b deposition on human erythrocytes induces the formation of a membrane skeleton-linked protein complex.NOD2-mediated suppression of CD55 on neutrophils enhances C5a generation during polymicrobial sepsis.Diagnostic surface expression of SWAP-70 on HIV-1 infected T cells.Predictors of hemoglobin response to eculizumab therapy in paroxysmal nocturnal hemoglobinuria.Shiga toxin 2 reduces complement inhibitor CD59 expression on human renal tubular epithelial and glomerular endothelial cellsAutoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS).Molecules Great and Small: The Complement System.Cerebral Stroke in a Teenage Girl with Paroxysmal Nocturnal Hemoglobinuria.Leukemia arising out of paroxysmal nocturnal hemoglobinuria.Glycolipid reanchoring of T-lymphocyte surface antigen CD8 using the 3' end sequence of decay-accelerating factor's mRNAA functional SNP in the regulatory region of the decay-accelerating factor gene associates with extraocular muscle pareses in myasthenia gravis.Complementary recognition of alternative pathway activators by decay-accelerating factor and factor HHuman IgM antibody therapy for HIV-1 infection.Pathogenesis of Afa/Dr diffusely adhering Escherichia coli.Decay-accelerating factor is expressed on vascular smooth muscle cells in human atherosclerotic lesions.Heightened complement sensitivity of acquired immunodeficiency syndrome lymphocytes related to diminished expression of decay-accelerating factor.Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patientsDeficiency of CC chemokine ligand 2 and decay-accelerating factor causes retinal degeneration in miceThe intrinsic complement regulator decay-accelerating factor modulates the biological response to vascular injuryConstruction, purification, and functional incorporation on tumor cells of glycolipid-anchored human B7-1 (CD80).Gene expression and transcription factor profiling reveal inhibition of transcription factor cAMP-response element-binding protein by gamma-herpesvirus replication and transcription activatorStructure-function analysis of decay-accelerating factor: identification of residues important for binding of the Escherichia coli Dr adhesin and complement regulation
P2860
Q24312892-53500176-D371-4B6D-933C-91FE22BE02A9Q24595979-5D1DFC88-7DAE-41E4-9E19-C3B817E86A49Q24599629-988ECFEB-23C6-42A1-8097-D6349CB5C493Q24613139-03A5D7BF-5F37-4480-9C89-F66ACB12A8F9Q24613512-DC13BD3B-4F4A-402F-8A30-5443622C5A70Q24648538-A5683C86-E06E-460C-9D81-5FCCC9E2D7C8Q24681862-FFA2CE30-5189-4CAB-A4D6-288D96F7F084Q26801300-6C25B1CE-1164-4F5B-834B-5EACB3502E4DQ26823956-23EA9435-563F-48D6-B84D-610EDD4CEF26Q26827470-D143EB29-DCCB-473F-A51E-4C2252D6A715Q26995453-CDAB82B4-14A7-4A93-B069-7063A77CF018Q27468625-8BBFE25C-71DE-4829-89A1-205773A32564Q27640215-0A8D94AD-E09B-4D95-B228-DBDA5757CE20Q27640881-502216F3-4217-48BF-AA4B-A48FBD5D2F98Q28139971-8761F961-51B8-43D4-BCD0-E89964FA4608Q28259136-A3CE5623-B2A8-4A1B-B5A3-C365FC32A3A9Q28504527-A2EF22AB-43AB-4DE8-AE46-4824A8813B32Q28610962-D1437FA1-1FCC-4968-A9B8-786E13A46A97Q30439939-225F9A2F-CD6E-4FFA-98E3-E9B61C233097Q31117454-62E92F93-420F-450C-92E5-67933303B4DCQ33237009-1D6922CB-AC48-463E-86E0-A3F59CA806E1Q33403710-25D7EAC3-10B7-4BB2-8883-FD804B369B97Q33407861-54F13768-593A-48CA-A403-30ECD07BECC5Q33417246-B667CDB3-FE5B-41F5-8677-7CFA2F8384C2Q33419651-923A5FAA-D9AD-451D-9706-399100E6784EQ33442790-129B1A06-1F62-4F33-8A7A-482C627556F6Q33536877-6D37201A-BEBD-49FF-909F-E75E8262F43AQ33575118-E85B5A32-553D-4F89-A729-26F17A9B4FF4Q33711147-8FC15A31-877E-4905-ABC2-2BFDC271DA18Q33749851-770CB4BC-2460-44D7-8F43-31C1A75C81F7Q33753260-E9451C79-D67A-487D-945E-DE40124D8159Q33755215-91E0EF39-FA68-420C-937E-738849B1F64FQ33848520-C2BFC10B-2312-4938-994D-3B01D20C4D23Q33867535-527CCAB7-5C0B-49C7-9ABD-FF03FCC219BEQ33902027-77C12AF0-415A-4A9A-9B14-A277F1450F92Q33902247-A6332F6B-100C-4731-A9F2-F3F6766E0DFCQ33990334-9966FC61-9C8D-43DF-A5D2-CA5B2495E263Q34027192-C9E1BAFC-EF85-42AA-BAE5-1A072AD9671EQ34055674-515D06D9-72EA-4803-9054-115D01B98241Q34127130-4DF1A258-A0D3-4416-938F-6EDA52D20529
P2860
Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes
description
1984 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1984
@ast
im November 1984 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1984/11/01)
@sk
vědecký článek publikovaný v roce 1984
@cs
wetenschappelijk artikel (gepubliceerd op 1984/11/01)
@nl
наукова стаття, опублікована в листопаді 1984
@uk
مقالة علمية (نشرت في نوفمبر 1984)
@ar
name
Inhibition of complement activ ...... tor (DAF) into their membranes
@ast
Inhibition of complement activ ...... tor (DAF) into their membranes
@en
Inhibition of complement activ ...... tor (DAF) into their membranes
@nl
type
label
Inhibition of complement activ ...... tor (DAF) into their membranes
@ast
Inhibition of complement activ ...... tor (DAF) into their membranes
@en
Inhibition of complement activ ...... tor (DAF) into their membranes
@nl
prefLabel
Inhibition of complement activ ...... tor (DAF) into their membranes
@ast
Inhibition of complement activ ...... tor (DAF) into their membranes
@en
Inhibition of complement activ ...... tor (DAF) into their membranes
@nl
P2093
P2860
P3181
P356
P1476
Inhibition of complement activ ...... tor (DAF) into their membranes
@en
P2093
M. E. Medof
T. Kinoshita
V. Nussenzweig
P2860
P304
P3181
P356
10.1084/JEM.160.5.1558
P407
P577
1984-11-01T00:00:00Z